· Published by Health Canada · Official notice
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
Australian Therapeutic Goods Administration (TGA)
Unknown
These products are promoted as natural health products used for weight loss.
The Australian Therapeutic Goods Administration warned consumers not to use Slimina weightloss capsules after they were found to contain undeclared sibutramine, and S-shape slim capsules after they were found to contain undeclared sibutramine, fenfluramine, phenolphthalein, propranolol and nifedipine.
Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side effects such as heart attack and stroke.
Fenfluramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with primary pulmonary hypertension (severe lung disease) and heart valve disease.
Phenolphthalein was previously used as a laxative but is no longer authorized for sale in Canada because it may cause cancer.
Propranolol is a prescription drug used to treat cardiovascular conditions such as high blood pressure, while nifedipine is a prescription drug used to treat high blood pressure and angina (heart-related chest pain). Propranolol and nifedipine should only be taken under the supervision of a health care practitioner.
In addition to heart attack and stroke, side effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.
Additional side-effects associated with fenfluramine include headache, drowsiness, dizziness, palpitation, diarrhea and dry mouth.
Additional side-effects associated with phenolphthalein include decreased blood pressure, skin rash and gastrointestinal bleeding.
Side effects associated with propranolol include decreased blood pressure, cold hands and feet, dizziness, fatigue, sexual dysfunction and difficulty breathing. Patients with cardiovascular conditions (high blood pressure, chest pain) should consult their health care practitioner before stopping S-shape slim capsules as suddenly stopping propranolol may cause serious side effects.
Side effects associated with nifedipine include headache, dizziness, fast heartbeat, flushing and swelling of the arms and legs.
Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.
Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.
Health Canada
613-957-2983
613-957-2991
1-866-225-0709